ON 203
Alternative Names: Monoclonal antibodies - OncoOne; ON-203; oxMIF targeting modalities - OncoOneLatest Information Update: 05 Dec 2022
At a glance
- Originator OncoOne
- Class Anti-inflammatories; Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Macrophage migration-inhibitory factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
- Discontinued Inflammation
Most Recent Events
- 26 Oct 2022 Pharmacodynamics data from preclinical studies in Solid tumours presented at the 34th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics (EORTC-NCI-AACR-2022)
- 06 Oct 2022 Discontinued - Preclinical for Inflammation in Austria (Parenteral) (OncoOne pipeline, October 2022)
- 28 Sep 2022 Pharmacodynamics data from a preclinical study in Solid tumours presented at the 6th Annual International Cancer, Immunotherapy Conference 2022 (CRI-ENCI-AACR-2022)